http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104031152-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104031152-B |
| titleOfInvention | Recombined pig/cow source escherichia coli heat stable enterotoxin fusion protein STp5-His, monoclonal antibody for resisting protein and application of protein |
| abstract | The invention discloses recombined pig/cow source escherichia coli heat stable enterotoxin (STp) fusion protein STp5-His, a monoclonal antibody for resisting the protein and application of the protein. The amino acid sequence of the fusion protein STp5-His is shown in SEQ ID NO.5, and the nucleotide sequence for coding the fusion protein STp5-His is shown in SEQ ID NO.3. The fusion protein STp5-His is expressed after mature peptide genes (estp) of pig/cow source escherichia coli heat stable enterotoxin (STp) are connected in series four times, and then natural STp protein without immunogenicity originally has good immunogenicity. The specific monoclonal antibody for the fusion protein STp-His and the natural STp is prepared through a cell fusion technique, the problem that in production practice, the STp cannot be detected is solved, and the specific monoclonal antibody can neutralize the natural STp in vitro and has a clinical application prospect. |
| priorityDate | 2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 324.